Singapore markets closed

Tenax Therapeutics, Inc. (TENX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.8400-0.0200 (-0.52%)
At close: 04:00PM EDT
3.7100 -0.13 (-3.39%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.52M
Enterprise value -1.77M
Trailing P/E N/A
Forward P/E 0.30
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.93
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.23

Trading information

Stock price history

Beta (5Y monthly) 2.27
52-week change 3-85.38%
S&P500 52-week change 322.38%
52-week high 361.2000
52-week low 33.4700
50-day moving average 33.9157
200-day moving average 316.9460

Share statistics

Avg vol (3-month) 3361.12k
Avg vol (10-day) 345.11k
Shares outstanding 51.96M
Implied shares outstanding 61.96M
Float 81.84M
% held by insiders 10.35%
% held by institutions 14.08%
Shares short (15 Apr 2024) 435.2k
Short ratio (15 Apr 2024) 40.66
Short % of float (15 Apr 2024) 41.80%
Short % of shares outstanding (15 Apr 2024) 41.80%
Shares short (prior month 15 Mar 2024) 436.72k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 326 Feb 2018
Ex-dividend date 4N/A
Last split factor 21:80
Last split date 303 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-68.21%
Return on equity (ttm)-160.79%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -8.23M
Net income avi to common (ttm)-7.71M
Diluted EPS (ttm)-31.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.79M
Total cash per share (mrq)5
Total debt (mrq)500.9k
Total debt/equity (mrq)6.19%
Current ratio (mrq)3.26
Book value per share (mrq)27.15

Cash flow statement

Operating cash flow (ttm)-5.9M
Levered free cash flow (ttm)-3.79M